Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2022-03-01
2023-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
1. Do 10 treatments of hyperbaric oxygen therapy induce significant changes in physical performance levels, vascular circulation, and concentrations of biochemical parameters in young, healthy men?
2. Does the body's response to 10 treatments of hyperbaric oxygen therapy differ depending on the frequency of treatments?
3. Does a series of hyperbaric oxygen therapy treatments induce significant changes in the composition of the intestinal microbiota, metabolome, and functional status of the intestines?
Participants are exposed to hyperoxia under hyperbaric conditions or form a control group with no treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of High-Intensity Interval Training (HIT) While in a Hyperoxic-Hyperbaric Environment on Exercise Performance
NCT02941939
The Impact of Physical Training Under Normobaric Hypoxia on Oxidative Stress Level, Inflammatory State, Intestinal Damage, and Mitochondrial Metabolism in Young Males
NCT06204731
Effects of Physical Training in Altered Environmental Conditions on Exercise Performance
NCT06159374
Effect of Training in Normobaric Hypoxia on Cardiac Markers
NCT06896773
Hyperbaric VO2max Study
NCT02356900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group 1: HBOT 3/week
The protocol comprises 10 Hyperbaric Oxygen Treatments (HBOT), 3 sessions per week.
Hyperbaric Oxygen Therapy - HBOT
Each session includes exposure of 60 minutes to 100% oxygen at 2.5 atmosphere absolute (ATA), with 5-minute air breaks every 20 minutes
Study Group 2: HBOT 6/week
The protocol comprises 10 Hyperbaric Oxygen Treatments (HBOT), 6 sessions per week.
Hyperbaric Oxygen Therapy - HBOT
Each session includes exposure of 60 minutes to 100% oxygen at 2.5 atmosphere absolute (ATA), with 5-minute air breaks every 20 minutes
Control Group
No changes to a daily routine.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperbaric Oxygen Therapy - HBOT
Each session includes exposure of 60 minutes to 100% oxygen at 2.5 atmosphere absolute (ATA), with 5-minute air breaks every 20 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy, physically active men;
* Subject who is knowingly willing to participate in the study;
* Subject able to read, understand and sign an informed consent to participate.
Exclusion Criteria
* Use of HBOT prior to study inclusion;
* Severe or unstable physical impairment or severe cognitive deficits at study entry;
* Pressure-sensitive chest diseases (including moderate or severe asthma) or pressure-sensitive ear or sinus diseases;
* Active smoking;
* Having suffered an injury within 3 months up to the date of the study;
* Taking pre- and/or probiotics in the last 3 months before the study;
* Inpatient hospital or emergency room stay in the last 4 weeks prior to study entry;
* Travel to tropical countries during the last 4 weeks prior to the study;
* Taking antibiotics, steroids and steroid-anabolic agents during the last 4 weeks before the study
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poznan University of Physical Education
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara Pospieszna, PhD.
Role: PRINCIPAL_INVESTIGATOR
Department of Athletics, Strength and Conditioning, Poznan Univ of Physical Ed, Poznan, Poland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Poznan University of Physical Education
Poznan, Wielkopolska, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AWF_LA_HBOT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.